RELA and pneumonitis: Among patients with asymptomatic pneumonitis, we observed no significant difference in median RELA levels before and after four cycles of durvalumab treatment (Figure S8A), with some patients showing an increase in RELA levels and others showing a decrease (paired Wilcoxon test, p = 0.0827) (Figure S8B).